Applied the α-2b interferon and ribavirin and thymus peptide in triad treatment for 30 patients with chronic Hepatitis C, and made a matched observation with the α-2b interferon and ribavirin in bi-treatment for them.The result manifest:the ALT normal-recovery rate was notably the group with triad treatment higher than that of the group with bi-treatment (P<0.01) , the HCVRNA met-negative rate the group with triad treatment was notably higher than that of the bi-treatment group.During the period with triad treatment, the side effects (the descent of hemochrome, anorexia, body weight loss, etc) were lower than those of the bi-treatment group.The triad treatment can improve the treatment effect for the chronic hepatitis C.
DownLoad: